Long non-coding RNA BCAR4 aggravated proliferation and migration in esophageal squamous cell carcinoma by negatively regulating p53/p21 signaling pathway

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
   PubMed Web of Science ®Google Scholar
• Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–86.
   PubMed Web of Science ®Google Scholar
• Malhotra GK, Yanala U, Ravipati A, et al. Global trends in esophageal cancer. J Surg Oncol. 2017;115(5):564–579.
   PubMed Web of Science ®Google Scholar
• Miller KD, Nogueira L, Mariotto AB, et al. Cancer treatment and survivorship statistics, 2019. CA Cancer J Clin. 2019;69(5):363–385.
   PubMed Web of Science ®Google Scholar
• Orom UA, Derrien T, Beringer M, et al. Long noncoding RNAs with enhancer-like function in human cells. Cell. 2010;143(1):46–58.
   PubMed Web of Science ®Google Scholar
• Zhang S, Liang Y, Wu Y, et al. Upregulation of a novel lncRNA LINC01980 promotes tumor growth of esophageal squamous cell carcinoma. Biochem Biophys Res Commun. 2019;513(1):73–80.
   PubMed Web of Science ®Google Scholar
• Wang H, Wu J, Guo W. SP1-mediated upregulation of lncRNA LINC01614 functions a ceRNA for miR-383 to facilitate glioma progression through regulation of ADAM12. Onco Targets Ther. 2020;13:4305–4318.
   PubMed Web of Science ®Google Scholar
• Shen W-J, Zhang F, Zhao X, et al. LncRNAs and esophageal squamous cell carcinoma - implications for pathogenesis and drug development. J Cancer. 2016;7(10):1258–1264.
   PubMed Web of Science ®Google Scholar
• Li HM, Yu YK, Liu Q, et al. LncRNA SNHG1 regulates the progression of esophageal squamous cell cancer by the miR-204/HOXC8 axis. Onco Targets Ther. 2020;13:757–767.
   PubMed Web of Science ®Google Scholar
• Sun Y, Wang J, Pan S, et al. LINC00657 played oncogenic roles in esophageal squamous cell carcinoma by targeting miR-615-3p and JunB. Biomed Pharmacother. 2018;108:316–324.
   PubMed Web of Science ®Google Scholar
• Godinho MF, Sieuwerts AM, Look MP, et al. Relevance of BCAR4 in tamoxifen resistance and tumour aggressiveness of human breast cancer. Br J Cancer. 2010;103(8):1284–1291.
   PubMed Web of Science ®Google Scholar
• Godinho M, Meijer D, Setyono-Han B, et al. Characterization of BCAR4, a novel oncogene causing endocrine resistance in human breast cancer cells. J Cell Physiol. 2011;226(7):1741–1749.
   PubMed Web of Science ®Google Scholar
• Godinho MF, Wulfkuhle JD, Look MP, et al. BCAR4 induces antioestrogen resistance but sensitises breast cancer to lapatinib. Br J Cancer. 2012;107(6):947–955.
   PubMed Web of Science ®Google Scholar
• van Agthoven T, Dorssers LC, Lehmann U, et al. Breast cancer anti-estrogen resistance 4 (BCAR4) drives proliferation of IPH-926 lobular carcinoma cells. PLoS One. 2015;10(8):e0136845.
   PubMed Web of Science ®Google Scholar
• Xing Z, Park PK, Lin C, et al. LncRNA BCAR4 wires up signaling transduction in breast cancer. RNA Biol. 2015;12(7):681–689.
   PubMed Web of Science ®Google Scholar
• Ouyang S, Zheng X, Zhou X, et al. LncRNA BCAR4 promotes colon cancer progression via activating Wnt/beta-catenin signaling. Oncotarget. 2017;8(54):92815–92826.
   PubMedGoogle Scholar
• Ouyang S, Zhou X, Chen Z, et al. LncRNA BCAR4, targeting to miR-665/STAT3 signaling, maintains cancer stem cells stemness and promotes tumorigenicity in colorectal cancer. Cancer Cell Int. 2019;19(1):72.
   PubMedGoogle Scholar
• Li N, Gao WJ, Liu NS. LncRNA BCAR4 promotes proliferation, invasion and metastasis of non-small cell lung cancer cells by affecting epithelial-mesenchymal transition. Eur Rev Med Pharmacol Sci. 2017;21(9):2075–2086.
   PubMed Web of Science ®Google Scholar
• Yang H, Yan L, Sun K, et al. lncRNA BCAR4 increases viability, invasion, and migration of non-small cell lung cancer cells by targeting glioma-associated oncogene 2 (GLI2). Oncol Res. 2019;27(3):359–369.
   PubMed Web of Science ®Google Scholar
• Cen B, Lang JD, Du Y, et al. Prostaglandin E2 induces miR675-5p to promote colorectal tumor metastasis via modulation of p53 expression. Gastroenterology. 2020;158(4):971–84 e10.
   PubMed Web of Science ®Google Scholar
• Liang X, Wu Z, Shen S, et al. LINC01980 facilitates esophageal squamous cell carcinoma progression via regulation of miR-190a-5p/MYO5A pathway. Arch Biochem Biophys. 2020;686:108371.
   PubMed Web of Science ®Google Scholar
• Liu AN, Qu HJ, Yu CY, et al. Knockdown of LINC01614 inhibits lung adenocarcinoma cell progression by up-regulating miR-217 and down-regulating FOXP1. J Cell Mol Med. 2018;22(9):4034–4044.
   PubMed Web of Science ®Google Scholar
• Chu J, Li H, Xing Y, et al. LncRNA MNX1-AS1 promotes progression of esophageal squamous cell carcinoma by regulating miR-34a/SIRT1 axis. Biomed Pharmacother. 2019;116:109029.
   PubMed Web of Science ®Google Scholar
• Xia Z, Yang X, Wu S, et al. LncRNA TP73-AS1 down-regulates miR-139-3p to promote retinoblastoma cell proliferation. Biosci Rep. 2019;39(5):5.
   Google Scholar
• Wang Y, Fang Q, Tian L, et al. Expression and regulatory network analysis of MiR-139-3p, a new potential serum biomarker for esophageal squamous cell carcinoma based on bioinformatics analysis. Technol Cancer Res Treat. 2020;19:1533033820920967.
   Web of Science ®Google Scholar
• Lafarga V, Cuadrado A, Lopez de Silanes I. p38 mitogen-activated protein kinase- and HuR-dependent stabilization of p21(Cip1) mRNA mediates the G(1)/S checkpoint. Mol Cell Biol. 2009;29(16):4341–4351.
   PubMed Web of Science ®Google Scholar
• Donahue JM, Chang ET, Xiao L, et al. The RNA-binding protein HuR stabilizes survivin mRNA in human oesophageal epithelial cells. Biochem J. 2011;437(1):89–96.
   PubMedGoogle Scholar
• Nakamura H, Kawagishi H, Watanabe A, et al. Cooperative role of the RNA-binding proteins Hzf and HuR in p53 activation. Mol Cell Biol. 2011;31(10):1997–2009.
   PubMed Web of Science ®Google Scholar
• Guha A, Ahuja D, Das Mandal S, et al. Integrated regulation of hur by translation repression and protein degradation determines pulsatile expression of p53 under DNA damage. iScience. 2019;15:342–359.
   PubMed Web of Science ®Google Scholar
• Zhang R, Wang J, Jia E, et al. lncRNA BCAR4 sponges miR3703p to promote bladder cancer progression via Wnt signaling. Int J Mol Med. 2020;45(2):578–588.
   PubMed Web of Science ®Google Scholar
• Wei L, Yi Z, Guo K, et al. Long noncoding RNA BCAR4 promotes glioma cell proliferation via EGFR/PI3K/AKT signaling pathway. J Cell Physiol. 2019;234(12):23608–23617.
   PubMed Web of Science ®Google Scholar
• Xue F, Li QR, Xu YH, et al. MicroRNA-139-3p inhibits the growth and metastasis of ovarian cancer by inhibiting ELAVL1. Onco Targets Ther. 2019;12:8935–8945.
   PubMed Web of Science ®Google Scholar
• Wang RA, Li QL, Li ZS, et al. Apoptosis drives cancer cells proliferate and metastasize. J Cell Mol Med. 2013;17(1):205–211.
   PubMed Web of Science ®Google Scholar
• Driak D, Dvorska M, Bolehovska P, et al. Bad and bid - potential background players in preneoplastic to neoplastic shift in human endometrium. Neoplasma. 2014;61(4):411–415.
   PubMed Web of Science ®Google Scholar
• Ghavami S, Hashemi M, Ande SR, et al. Apoptosis and cancer: mutations within caspase genes. J Med Genet. 2009;46(8):497–510.
   PubMed Web of Science ®Google Scholar
• Lee YY, Mok MT, Kang W, et al. Loss of tumor suppressor IGFBP4 drives epigenetic reprogramming in hepatic carcinogenesis. Nucleic Acids Res. 2018;46(17):8832–8847.
   PubMed Web of Science ®Google Scholar
• Harper JW, Adami GR, Wei N, et al. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell. 1993;75(4):805–816.
   PubMed Web of Science ®Google Scholar
• Bukholm IK, Nesland JM. Protein expression of p53, p21 (WAF1/CIP1), bcl-2, Bax, cyclin D1 and pRb in human colon carcinomas. Virchows Arch. 2000;436(3):224–228.
   PubMed Web of Science ®Google Scholar
• North S, El-Ghissassi F, Pluquet O, et al. The cytoprotective aminothiol WR1065 activates p21waf-1 and down regulates cell cycle progression through a p53-dependent pathway. Oncogene. 2000;19(9):1206–1214.
   PubMed Web of Science ®Google Scholar
• Dai M, Al-Odaini AA, Fils-Aime N, et al. Cyclin D1 cooperates with p21 to regulate TGFbeta-mediated breast cancer cell migration and tumor local invasion. Breast Cancer Res. 2013;15(3):R49.
   PubMed Web of Science ®Google Scholar
• Qian X, Hulit J, Suyama K, et al. p21CIP1 mediates reciprocal switching between proliferation and invasion during metastasis. Oncogene. 2013;32(18):2292–2303.
   PubMed Web of Science ®Google Scholar